From: Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review
Total cohort (n = 69) | ≥ 2 years (n = 31) | < 2 years (n = 38) | |||||||
---|---|---|---|---|---|---|---|---|---|
Yes | No | NR | Yes | No | NR | Yes | No | NR/NA | |
Short and bowed limbs | 69 (100%) | – | – | 31 (100%) | – | – | 38 (100%) | – | – |
Camptodactyly | 55 (80%) | 2 | 12 | 25 (81%) | 2 | 4 | 30 (79%) | – | 8 |
Joint mobility restriction | 45 (65%) | 5 | 19 | 25 (81%) | 2 | 4 | 20 (53%) | 3 | 15 |
Fractures | 21 (30%) | 18 | 30 | 19 (61%) | 12 | – | 2 (5%) | 6 | 30 |
Osteoporosis/osteopenia | 19 (28%) | 2 | 48 | 15 (48%) | – | 16 | 4 (11%) | 2 | 32 |
Spinal deformation | 30 (44%) | 21 | 18 | 24 (77%) | 5 | 2 | 6 (16%) | 16 | 16 |
Feet malposition | 35 (51%) | 9 | 25 | 14 (45%) | 8 | 9 | 21 (55%) | 1 | 16 |
Growth retardation | 39 (57%) | 5 | 25 | 27 (87%) | 1 | 3 | 12 (32%) | 4 | 22 |